Maxim Group Starts Stock Coverage on Athersys (ATHX)

By admin | 6 years ago

Equities researchers at Maxim Group began coverage on shares of Athersys (NASDAQ: ATHX) in a report issued on Thursday. The firm set a “buy” rating and a $3.00 price target on the stock.

Shares of Athersys traded down 3.38% during mid-day trading on Thursday, hitting $1.43. Athersys has a 52 week low of $1.00 and a 52 week high of $2.90. The company’s market cap is $42.0 million.

Separately, analysts at Piper Jaffray (NYSE: PJC) initiated coverage on shares of Athersys in a research note to investors on Tuesday, March 20th. They set an “overweight” rating and a $4.00 price target on the stock.

Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.

About the author